Astra sues as more generic firms threaten Crestor
LONDON (Reuters) – AstraZeneca Plc said on Wednesday it had filed patent infringement actions in the United States against seven generic drugmakers, which have submitted plans to sell generic versions of its cholesterol pill Crestor.
About Pete Southern
Pete Southern is an active trader, chartist and writer for market blogs. He is currently technical analysis contributor and admin at this here blog.
Most Popular Content
- S&P 500 Grinds Higher as Rate Cut Hopes Simmer
- Bitcoin Holds Near $120K as 401(k) Buzz Meets Inflation Jitters
- Pound Climbs on BoE Cut and Dovish Signals
- Gold Soars on Tariff Shock as Copper Holds Steady
- Markets Wobble After Highs as Fed Holds Steady and Earnings Send Mixed Signals
- Copper Prices Drift in the Wake of a Surprise Tariff Shock
- Gold Prices Retreat from Highs Amid Easing Geopolitical Tensions
- Inflation Data and What Is Next For The British Pound?
Currency Articles - Aug 13, 2025 1:07 - 0 Comments
Bitcoin Holds Near $120K as 401(k) Buzz Meets Inflation Jitters
More In Currency Articles
Gold and Oil News - Aug 9, 2025 6:33 - 0 Comments
Gold Soars on Tariff Shock as Copper Holds Steady
More In Gold and Oil News
- Copper Prices Drift in the Wake of a Surprise Tariff Shock
- Gold Prices Retreat from Highs Amid Easing Geopolitical Tensions